CBLN1 and Alzheimer disease: Altered CER chain length distribution leads to aberrant lipid organization (increased hexagonal packing) and compromises epidermal barrier function in AD patients, correlating with TEWL values and disease severity but not with FLG status—CER [EOH] and CER [AS] show the strongest associations [92,115,116].